Comparison of Transplanted Kidney Function in Patients on Two Different Doses of Mycophenolate Mofetil

Transplantation Proceedings

Volumn 38, Issue 7, 2006, Pages 2035-2037

  Khosroshahi, H T ^a   Nahali, A ^b   Gojazadeh, M ^a   Shoja, M M ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Orumieh Medical University   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; AGE; ARTICLE; BLOOD TOXICITY; COMPARATIVE STUDY; CREATININE BLOOD LEVEL; DIARRHEA; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ECONOMIC ASPECT; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; GENDER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY FUNCTION TEST; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECIPIENT; STATISTICAL ANALYSIS; UREA BLOOD LEVEL;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PREDNISOLONE;

EID: 33846113324     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.06.040     Document Type: Article

References (9)

1. Mourad M., Malaise J., Chaib Eddour D., et al. Pharmacokinetic basis for the efficient and safe use of low-dose mycophenolate mofetil in combination with tacrolimus in kidney transplantation. Clin Chem 47 (2001) 1241
2. Mourad M., Malaise J., Chaib E.D., et al. Correlation of mycophenolic acid pharmacokinetic parameters with side effects in kidney transplant patients treated with mycophenolate mofetil. Clin Chem 47 (2001) 88
3. Pelletier R.P., Akin B., Henry M.L., et al. The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation. Clin Transplant 17 (2003) 200
4. Knoll G.A., MacDonald I., Khan A., et al. Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation. J Am Soc Nephrol 14 (2003) 2381
5. Kahu J., Kyllonen L., and Salmela K. Impact of mycophenolate mofetil intolerance on early results of kidney transplantation. Transplant Proc 37 (2005) 3276
6. ter Meulen C.G., Gregoor P.J., Weimar W., et al. Elective withdrawal of mycophenolate mofetil in renal transplant recipients treated with mycophenolate mofetil, cyclosporine, and prednisone. Transpl Int 14 (2001) 99
7. Kaplan B., Meier-Kriesche H.U., Vaghela M., et al. Withdrawal of mycophenolate mofetil in stable renal transplant recipients. Transplantation 69 (2000) 1726
8. Warrens A.N. The evolving role of mycophenolate mofetil in renal transplantation. QJM 93 (2000) 15
9. Miller J., Mendez R., Pirsch J.D., et al. Safety and efficacy of tacrolimus in combination with mycophenolate mofetil in cadaveric renal transplant recipients. Transplantation 69 (2000) 850